Rheaplant
PrivateLast Round
Accelerator
May 18, 2026
Total Funding Raised
$200,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rheaplant operates in Healthcare & Life Sciences and is based in Oakland, California. Its latest recorded funding round was an Accelerator round in May 2026.
Rheaplant is a biotechnology company that develops modular, purpose-built plant cell bioprocessing platforms to enable the cost-effective production of botanical ingredients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rheaplant Comparables
Compare Rheaplant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ayana Bio | 85% | |
| Chi Botanic | 84% | |
| California Cultured | 83% |
For institutional investors. Book with your work email.
Rheaplant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 18, 2026 | ||||
| Pre Seed | Aug 1, 2025 |
For institutional investors. Book with your work email.
Rheaplant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Big Idea Ventures | Accelerator |
| 2045 Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
$200K round led by Big Idea Ventures.
For institutional investors. Book with your work email.
Rheaplant Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rheaplant's valuation, stock price, and market status.
Is Rheaplant a public or private company?
Rheaplant is a private company.
What is the current stock price of Rheaplant?
Rheaplant is a private company, so its shares have no public market price. Caplight tracks Rheaplant's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rheaplant worth (valuation)?
Valuation information for Rheaplant is not publicly available.
Can I buy Rheaplant stock?
Rheaplant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rheaplant's last funding round?
Rheaplant's most recent funding round was Accelerator on May 18, 2026.
Who are the main investors in Rheaplant?
Key investors in Rheaplant include Big Idea Ventures.
Will Rheaplant IPO soon?
No public IPO plans have been announced for Rheaplant.
How can I track Rheaplant secondary market activity?
Caplight tracks bids, offers, and trades in Rheaplant's shares on secondary markets.